BiotechTube

Sitagliptin-Metformin + Metformin + Placebo pill

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Disorder of Glucose Regulation

Conditions

Disorder of Glucose Regulation

Trial Timeline

Sep 28, 2013 → Sep 28, 2017

NCT ID
NCT01856907

About Sitagliptin-Metformin + Metformin + Placebo pill

Sitagliptin-Metformin + Metformin + Placebo pill is a approved stage product being developed by Merck for Disorder of Glucose Regulation. The current trial status is completed. This product is registered under clinical trial identifier NCT01856907. Target conditions include Disorder of Glucose Regulation.

What happened to similar drugs?

20 of 20 similar drugs in Disorder of Glucose Regulation were approved

Approved (20) Terminated (2) Active (0)
✅Olanzapine + PlaceboEli LillyApproved
✅atomoxetineEli LillyApproved
✅AtomoxetineEli LillyApproved
✅Duloxetine (Cymbalta)Eli LillyApproved
✅Atomoxetine HydrochlorideEli LillyApproved
✅AtomoxetineEli LillyApproved
✅Atomoxetine hydrochloride + PlaceboEli LillyApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01856907ApprovedCompleted

Competing Products

20 competing products in Disorder of Glucose Regulation

See all competitors
ProductCompanyStageHype Score
Duloxetine + venlafaxine + placeboEli LillyPhase 3
40
Ketamine + PlaceboRoivant SciencesPhase 1
26
duloxetineEli LillyPre-clinical
26
SUBLOCADEIndivior PLCPhase 3
29
SUBLOCADEIndivior PLCPhase 3
29
TSHA-101Taysha Gene TherapiesPhase 1/2
30
OlanzapineEli LillyPhase 3
32
Valproate + Lithium + Risperidone + OlanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyApproved
43
Duloxetine HydrochlorideEli LillyPre-clinical
26
LY2216684Eli LillyPhase 1
29
ACT-541468 5 mg + ACT-541468 10 mg + ACT-541468 25 mg + Zolpidem + Placebo 1 + Placebo 2IdorsiaPhase 2
29
LY2216684Eli LillyPhase 1
29
atomoxetineEli LillyApproved
39
Atomoxetine + PlaceboEli LillyPhase 2/3
38
LY2422347 + placeboEli LillyPhase 2
35
Low Dose REN001 + High Dose REN001OnKure TherapeuticsPhase 1
19
AtomoxetineEli LillyApproved
35
DuloxetineEli LillyPhase 3
40
Duloxetine (Cymbalta)Eli LillyApproved
43